Kirsten L. Gruis's most recent trade in DiaMedica Therapeutics Inc was a trade of 67,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
DiaMedica Therapeutics Inc | Kirsten L. Gruis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
DiaMedica Therapeutics Inc | Kirsten L. Gruis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 160,000 | 160,000 | - | - | Stock Option (right to buy) |